Edit |   |
---|---|
Antigenic Specificity | CD86 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.1 mg |
Concentration | 1 mg/mL |
Applications | ELISA (EIA), Western Blot (WB) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: At least five isoforms of CD86 are known to exist; this antibody will detect all five isoforms. CD86, also known as B7-2, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD80, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhan |
Immunogen | Immunogen: CD86 antibody was raised against a peptide corresponding to 17 amino acids near the center of human CD86. The immunogen is located within amino acids 160 - 210 of CD86. Buffer: CD86 Antibody is supplied in PBS containing 0.02% sodium azide. |
Other Names | [CD86; CD86 molecule; B70; B7-2; B7.2; LAB72; CD28LG2], [CD86; CD86; B70; B7-2; B7.2; LAB72; CD28LG2; CD28LG2] |
Gene, Accession # | [CD86], Gene ID: 942, NCBI: NP_787058, UniProt: P42082 |
Catalog # | MBS154468 |
Price | $375 |
Order / More Info | CD86 Antibody from MYBIOSOURCE INC. |
Product Specific References | 1. Lane P. Regulation of T and B cell responses by modulating interactions between CD28/CTLA-4 and their ligands, CD80 and CD86. Ann NY Acad Sci 1997; 815:392-400. 2. Feucht J, Kayser S, Gorodezki D, et al. T-cell responses against CD19 pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts. Oncotarget 2016; 7:76902-19. |